AB0310 TROUGH CONCENTRATION AND ESTIMATED CLEARANCE CAN DETECT IMMUNOGENICITY TO ADALIMUMAB IN RA PATIENTS: A PROSPECTIVE LONGITUDINAL MULTICENTRE STUDY

MLA

Aude Gleizes, et al. “Ab0310 Trough Concentration and Estimated Clearance Can Detect Immunogenicity to Adalimumab in Ra Patients: A Prospective Longitudinal Multicentre Study.” Annals of the Rheumatic Diseases, vol. 79, June 2020, p. 1453.1-1454. EBSCOhost, https://doi.org/10.1136/annrheumdis-2020-eular.2809.

APA

Aude Gleizes, Sebastian Spindeldreher, Denis Mulleman, J. Avouac, Florian Deisenhammer, Xavier Mariette, Natacha Szely, Gilles Paintaud, Jessica J Manson, Olivier Brocq, Céline Desvignes, S. Hacein-Bey, J. Elhasnaoui, David Ternant, Pierre Dönnes, Martin Soubrier, Marc Pallardy, Christophe Richez, & Anna Fogdell-Hahn. (2020). Ab0310 Trough Concentration and Estimated Clearance Can Detect Immunogenicity to Adalimumab in Ra Patients: A Prospective Longitudinal Multicentre Study. Annals of the Rheumatic Diseases, 79, 1453.1-1454. https://doi.org/10.1136/annrheumdis-2020-eular.2809

Chicago

Aude Gleizes, Sebastian Spindeldreher, Denis Mulleman, J. Avouac, Florian Deisenhammer, Xavier Mariette, Natacha Szely, et al. 2020. “Ab0310 Trough Concentration and Estimated Clearance Can Detect Immunogenicity to Adalimumab in Ra Patients: A Prospective Longitudinal Multicentre Study.” Annals of the Rheumatic Diseases 79 (June): 1453.1-1454. doi:10.1136/annrheumdis-2020-eular.2809.